Exploring the intricate links between the environment and respiratory function, environmental & occupational lung health addresses the impact of air pollution, chemical exposures, and workplace hazards on pulmonary disease incidence. Chronic exposure to particulate matter, volatile organic compounds, and occupational allergens is strongly associated with diseases like COPD, hypersensitivity pneumonitis, and pneumoconiosis. Increasing attention is being given to identifying and mitigating newer risk factors such as nanomaterial inhalation, indoor biomass smoke, and emissions from industrial solvents. Technological advancements are enabling more precise exposure assessment and real-time monitoring, helping clinicians and researchers better understand dose-response relationships. There is also a growing emphasis on multidisciplinary approaches that integrate occupational medicine, environmental science, and public health to shape effective interventions. Efforts to reduce disparities in exposure and improve workplace standards are gaining momentum as part of a broader push toward sustainable respiratory health practices.
Title : Screening questionnaires for obstructive sleep apnea: An updated systematic review
Behzad Rahmati, Isfahan University of Medical Sciences, Iran (Islamic Republic of)
Title : Improving covid 19 candidate vaccine response through probiotics and micronutrient supplementation: Evaluating the role of TLR5
Zohre Eftekhari, Biotechnology Research Center, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Iatrogenic pneumothorax following nephrectomy: Case report
Chaimae Tahiri, National University Hospital Center of Fann, Senegal
Title : Towards the experience and view of personalized and precision pulmonology: An option for clinicians, geneticists and caregivers to realize the potential of genomics informed lung cancer care to secure the individualized human biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Opioid induced hypoventilation and sleep related hypoxemia in a patient on buprenorphine naloxone an underrecognized problem.
Anusha Devarajan, University of Vermont Medical Center, United States